Mode
Text Size
Log in / Sign up
Phase 2 Completed N=27 Randomized Quadruple-blind Treatment

Effects of Melatonin on Insomnia Symptoms in Older Adults

Sleep Initiation and Maintenance Disorders
Source: ClinicalTrials.gov NCT00230737 ↗
Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Peak Melatonin Level — 405; 3999; 52 pg/ml — p=<0.001

Summary

This study will determine whether melatonin tablets will increase the sleep of older adults with insomnia.

Outcome Measures

OutcomeResultp-value
PRIMARY
Peak Melatonin Level
405; 3999; 52 <0.001 sig

Eligibility Criteria

Inclusion Criteria

  • History of insomnia
  • Low melatonin levels at study entry

Exclusion Criteria

  • History of sleep apnea (temporary cessation of breathing during sleep)
  • Diagnosis of restless legs syndrome
  • Current alcohol or substance abuse
  • Dementia
  • Anemia
  • Liver disease
  • Leukemia or lymphoma
  • Asthma
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00230737). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search